Search results for

The United Kingdom (UK) has left the European Economic Area (EEA) single market and customs union.

If you are an establishment based in Great Britain (GB) that imports or exports human tissues or cells for human application between GB and a country in th...

The regulatory changes introduced at the end of the UK Transition Period differ for Great Britain (GB) and Northern Ireland (NI) as the Government ensures...

Since 1 January 2021, the United Kingdom (UK) has operated a full border with the European Economic Area (EEA).

The Regulations that retain the existing quality and safety standards and provide legal and regulatory certainty after the end of the UK Transition Period...

Assessment tool to demonstrate that imported tissues and cells meet equivalent standards of quality and safety to those required by the Human Tissue (Qua

The HTA-related licensing changes introduced at the end of the UK Transition Period affect some establishments that previously did not require an HTA licen...

The six-month phase for Human Application sector establishments to comply with new import and export licensing requirements ended on 1 July 2021.

Find out more about our Board, and other standing committees.

Throughout the year we host a programme of stakeholder engagement events.

The HTA Audit Committee is an advisory body to the Human Tissue Authority board (the Authority). The main functions of the Audit Committee are to:

The duties of the Remuneration Committee are to:

The HTA has a responsibility to make its information available in accordance with the Freedom of Information Act. Before making a Freedom of Informa

You can browse and read previous FOI responses below.